Related Experiment Videos
Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study
1Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong.
Abstract:
This report presents a prospective randomized study of 0.3 percent ofloxacin eardrops for the treatment of active chronic suppurative otitis media. Twenty-nine patients were treated with ofloxacin eardrops for 1 week, and another 27 patients were treated with Augmentin for 1 week. One week after completion of treatment, 22 (76%) patients of the group treated with ofloxacin had dry ears, and only seven (26%) patients treated with Augmentin had dry ears. Ofloxacin eardrops were effective in the initial treatment of active chronic suppurative otitis media.
Insights
This study found that 0.3% ofloxacin eardrops effectively treated active chronic suppurative otitis media. Ofloxacin resulted in significantly more dry ears compared to Augmentin after one week of treatment.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Pharmacology
Background:
- Chronic suppurative otitis media (CSOM) is a common ear infection.
- Effective treatment options for active CSOM are crucial to prevent complications.
Purpose of the Study:
- To compare the efficacy of 0.3% ofloxacin eardrops versus Augmentin for treating active CSOM.
- To evaluate the rate of ear dryness as a primary outcome measure.
Main Methods:
- A prospective randomized study was conducted.
- 29 patients received 0.3% ofloxacin eardrops, and 27 patients received Augmentin.
- Treatment duration was one week for both groups.
Main Results:
- After one week post-treatment, 76% of ofloxacin-treated patients achieved dry ears.
- Only 26% of Augmentin-treated patients had dry ears.
- Ofloxacin demonstrated a significantly higher success rate.
Conclusions:
- 0.3% ofloxacin eardrops are effective for the initial treatment of active chronic suppurative otitis media.
- Ofloxacin offers a superior initial treatment outcome compared to Augmentin for CSOM.